Friday Jun 27
Celsion Director Purchases $16,800 in Stock
Celsion Director Alberto R. Martinez, Jr. bought 5,000 shares of the company's stock in a transaction dated Thursday, June 26th.
Celsion Corporation Completes Acquisition Of EGEN, Inc.
The acquisition includes EGEN's Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas for delivery of DNA and mRNA, TheraSilence for delivery of RNA, and RAST for Cell Enabled Expression and Secretion of RNA.
Insider Buying: Michael H. Tardugno Purchases 5,000 Shares of Celsion Stock
Celsion CEO Michael H. Tardugno purchased 5,000 shares of Celsion stock on the open market in a transaction that occurred on Wednesday, June 11th.
Celsion Corporation Scoops Up Privately-Held For $14 Million Including Debts
Under the terms of the agreement, a wholly-owned subsidiary of Celsion will acquire the assets of EGEN and assume certain liabilities in exchange for cash and shares of Celsion totaling in Celsion common stock is subject to a twenty-four month holdback by Celsion for expense adjustment and certain indemnification claims of Celsion, and in future ... (more)